How safe is blood, really?

Biologicals

Volumn 38, Issue 1, 2010, Pages 100-104

  Klein, Harvey G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood safety; Transfusion; Transfusion risks

Indexed keywords

ANTIGEN; BLOOD SUBSTITUTE; CHEMOKINE; CYTOKINE;

ARTICLE; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CULTURAL FACTOR; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMIC ASPECT; ERYTHROCYTE TRANSFUSION; FILTRATION; GEOGRAPHIC DISTRIBUTION; HEART SURGERY; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY; SOCIAL CLASS; SURVIVAL; TRAUMATOLOGY; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; CONSUMER PRODUCT SAFETY; HUMANS; MODELS, BIOLOGICAL; SAFETY MANAGEMENT;

EID: 77649185940     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.10.008     Document Type: Article

References (46)

1. Blundell J. Observations on the transfusion of blood. Lancet 2 ii (1828) 321-324
2. Alter H.J., and Klein H.G. The hazards of blood transfusion in historical perspective. Blood 112 7 (2008) 2617-2626
3. Vamvakas E.C., and Blajchman M.A. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113 15 (2009) 3406-3417
4. Dzik W.H. Emily Cooley lecture 2002: transfusion safety in the hospital. Transfusion 43 (2003) 1190-1199
5. Klein H.G., Spahn D.R., and Carson J.L. Red blood cell transfusion in clinical practice. Lancet 370 9585 (2007) 415-426
6. Slichter S.J. Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program (2007) 172-178
7. Gajic O., Dzik W.H., and Toy P. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?. Crit Care Med 34 5 Suppl (2006) S170-S173
8. Crosby W.H. Misuse of blood transfusion. Blood 13 (1958) 1198-1200
9. van der Poel C.L. Remuneration of blood donors: new proof of the pudding?. Vox Sang 94 3 (2008) 169-170
10. (2009). http://anthro.palomar.edu/vary/vary_3.htm [Accessed 3 July]
11. Wagner F.F., and Flegel W.A. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion 35 4 (1995) 284-291
12. Dodd R.Y., Notari E.P., and Stramer S.L. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 (2002) 975-979
13. Pillonel J., and Laperche S. Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing). Transfus Clin Biol 11 (2004) 81-86
14. Alter H.J., Stramer S.L., and Dodd R.Y. Emerging infectious diseases that threaten the blood supply. Semin Hematol 44 1 (2007 Jan) 32-41
15. Clarke P., Will R.G., and Ghani A.C. Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?. J R Soc Interface 4 15 (2007) 675-684
16. Marshall D.A., Kleinman S.H., Wong J.B., AuBuchon J.P., Grima D.T., Kulin N.A., et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 86 1 (2004) 28-40
17. Kilduffe R.A., and DeBakey M. The blood bank and the techniques and therapeutics of transfusion (1942), Mosby, St Louis. MO
18. Linden J.V., Wagner K., Voytovich A.E., and Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 40 (2000) 1207-1213
19. Dzik W.H., Murphy M.F., Andreu G., Heddle N., Szczepiorkowski Z., Wendel S., et al. An international study of the performance of sample collection from patients. Vox Sang 85 (2003) 40-47
20. Pittman M. A study of bacteria implicated in transfusion reactions and of bacteria isolated from blood products. J Lab Clin Med 42 (1953) 273-288
21. Kuehnert M.J., Roth V.R., Haley N.R., Gregory K.R., Elder K.V., Schreiber G.B., et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 41 (2001) 1493-1499
22. Eder A.F., Kennedy J.M., Dy B.A., Notari E.P., Skeate R., Bachowski G., et al. The American Red Cross Regional Blood Centers. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion (2009 Apr 28) [Epub ahead of print]
23. Bryant B.J., and Klein H.G. Pathogen inactivation: the definitive safeguard for the blood supply. Arch Pathol Lab Med 131 (2007) 719-733
24. Murphy C.V., Eakins E., Fagan J., Croxon H., and Murphy W.G. In vitro assessment of red-cell concentrates in SAG-M filtered through the MacoPharma P-CAPT prion-reduction filter. Transfus Med 19 3 (2009) 109-116
25. Klein H.G. Getting older is not necessarily getting better. Anesthesiology 98 4 (2003) 807-808
26. Klein H.G. Immunomodulatory aspects of transfusion: a once and future risk. Anesthesiology 91 3 (1999) 861-865
27. Bilgin Y.M., and Brand A. Transfusion-related immunomodulation: a second hit in an inflammatory cascade?. Vox Sang 95 (2008) 261-271
28. Malone D.L., Dunne J., Tracy J.K., Putnam A.T., Scalea T.M., and Napolitano L.M. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54 (2003) 898-905
29. Palmieri T.L., Caruso D.M., Foster K.N., Cairns B.A., Peck M.D., Gamelli R.L., et al. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med 34 (2006) 1602-1607
30. Koch C.G., Li L., Duncan A.I., Mihaljevic T., Cosgrove D.M., Loop F.D., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 (2006) 1608-1616
31. Taylor R.W., O'Brien J., Trottier S.J., Manganaro L., Cytron M., Lesko M.F., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 34 (2006) 2302-2308
32. Vincent J.L., Sakr Y., Sprung C., Harboe S., and Damas P. Sepsis occurrence in acutely Ill Patients (SOAP) investigators: are blood transfusions associated with greater mortality rates?. Results of the sepsis occurrence in acutely Ill patients study. Anesthesiology 108 (2008) 31-39
33. Marik P.E., and Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 36 (2008) 2667-2674
34. Purdy F.R., Tweeddale M.G., and Merrick P.M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 44 (1997) 1256-1261
35. Leal-Noval S.R., Jara-López I., and García-Garmendia J.L. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 98 (2003) 815-822
36. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 12 (2008 Mar 20) 1229-1239
37. Dzik W.H. Fresh blood for everyone?. Balancing availability and quality of stored RBCs. Transfus Med 18 4 (2008) 260-265
38. Weiskopf R.B., Feiner J., Hopf H., Lieberman J., Finlay H.E., Quah C., et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 104 5 (2006) 911-920
39. Brandt L., Brandt J., Olsson H., Anderson H., and Möller T. Blood transfusion as a risk factor for non-Hodgkin lymphoma. Br J Cancer 73 9 (1996) 1148-1151
40. Skanberg J., and Frisk B. Blood transfusion does not influence the development of malignant tumours. Eur J Surg 165 6 (1999) 528-534
41. Hjalgrim H., Edgren G., Rostgaard K., Reilly M., Tran T.N., Titlestad K.E., et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst 99 24 (2007) 1864-1874
42. Kamper-Jørgensen M., Ahlgren M., Rostgaard K., Melbye M., Edgren G., Nyrén O., et al. Transfusion 48 12 (2008) 2577-2584
43. Powell J.S. Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag 5 2 (2009) 391-402
44. Klein H.G. Blood substitutes: how close to a solution?. Dev Biol (Basel) 120 (2005) 45-52
45. Natanson C., Kern S.J., Lurie P., Banks S.M., and Wolfe S.M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299 19 (2008) 2304-2312
46. Douay L. Cell culture for transfusion purposes: the concept of "cultured red blood cells". Transfus Clin Biol 16 2 (2009) 134-137